54699-43-3

Basic information

• Product Name: 8-(Tetrahydro-2H-pyran-2-yloxy)octanoic acid
• Synonyms: 8-(Tetrahydro-2H-pyran-2-yloxy)octanoic acid;8-[(Tetrahydro-2H-pyran-2-yl)oxy]octanoic acid
• CAS NO: 54699-43-3
• Molecular Formula: C₁₃H₂₄O₄
• Molecular Weight: 244.33
• Mol File: 54699-43-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 386.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• PKA: 4.77±0.10(Predicted)
• CAS DataBase Reference: 8-(Tetrahydro-2H-pyran-2-yloxy)octanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 8-(Tetrahydro-2H-pyran-2-yloxy)octanoic acid(54699-43-3)
• EPA Substance Registry System: 8-(Tetrahydro-2H-pyran-2-yloxy)octanoic acid(54699-43-3)

Safety Data

• Hazardous Substances Data: 54699-43-3(Hazardous Substances Data)

Upstream product

• 629-41-4 1,8-Octanediol 
• 51326-52-4 8-(tetrahydro-2H-pyran-2-yloxy)octan-1-ol 
• 110-87-2 3,4-dihydro-2H-pyran 
• 57221-80-4 8-tetrahydropyranyloxyoctanal 
• 17696-11-6 8-bromooctanoic acid 
• 764-89-6 8-hydroxycaprylic acid 

Downstream Products

• 93892-06-9 8-hydroxyoctanoic acid ethyl ester 

Relevant articles and documents

Synthesis and olfactory properties of regioisomeric alkynolides and (Z)- alkenolides

A general approach to the title compounds (Z)-9a-d via 8a-d from easily available starting materials is presented. The olfactory properties of these macrolides are discussed. A new synthesis of the precursor 7e of (Z)- ambrettolide (1) is also described.

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

Provided herein are lipid compounds that can be used in combination with other lipid components, such as neutral lipids, cholesterol and polymer conjugated lipids, to form lipid nanoparticles for delivery of therapeutic agents (e.g., nucleic acid molecules) for therapeutic or prophylactic purposes, including vaccination. Also provided herein are lipid nanoparticle compositions comprising said lipids.

NOVEL DIHYDROXYBENZENE DERIVATIVES AND ANTIPROTOZOAL AGENT COMPRISING SAME AS ACTIVE INGREDIENT

Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; R1 represents a hydrogen atom; R2 represents a hydrogen atom or a C1-7 alkyl group; R3 represents -CHO, -C(=O)R5, -COOR5 (wherein R5 represents a C1-7 alkyl group), -CH2OH or -COOH; and R4 represents a C1-16 alkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a C2-16 alkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a C2-16 alkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.